BioCryst Pharmaceuticals, Inc. (BCRX) Stock News, Earnings & History
(NASDAQ:BCRX) Healthcare
Enjoy Interactive Tools and Indicators
52wk high:
4.95
52wk low:
1.08
EPS:
-0.74
P/E:
N/A
Div Rate:
N/A
Yield:
N/A
Market Cap:
90.35M
Avg Vol (3m):
1.48M
Latest Headlines
Insider Trading Cheat Sheet
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
| Jensen Peder | Director | Dec 14 | Buy | 1.51 | 20,000 | 30,200 | 60,000 | Dec 17 12:10 PM |
| Jensen Peder | Director | Jun 05 | Buy | 3.18 | 20,000 | 63,680 | 40,000 | Jun 05 07:38 PM |
| SANDERS CHARLES A | Director | Mar 13 | Buy | 5.22 | 2,000 | 10,430 | 7,000 | Mar 15 12:21 PM |
| Stonehouse Jon P | President & CEO | Mar 02 | Sale | 4.78 | 2,721 | 13,006 | 239,384 | Mar 05 05:09 PM |
| Sheridan William P | SR VP - CMO | Mar 02 | Sale | 4.78 | 956 | 4,570 | 29,330 | Mar 05 03:38 PM |
| McCullough David | VP | Mar 02 | Sale | 4.78 | 574 | 2,744 | 13,926 | Mar 05 02:58 PM |
| Babu Yarlagadda S | VP Drug Discovery | Mar 02 | Sale | 4.78 | 837 | 4,001 | 125,769 | Mar 05 02:30 PM |
| Babu Yarlagadda S | VP Drug Discovery | Feb 29 | Option Exercise | 0.00 | 53,668 | 0 | 106,406 | Mar 01 02:59 PM |
| Babu Yarlagadda S | VP Drug Discovery | Feb 22 | Option Exercise | 1.19 | 30,912 | 36,781 | 83,650 | Feb 23 04:40 PM |
| Babu Yarlagadda S | VP Drug Discovery | Feb 22 | Sale | 4.22 | 30,912 | 130,449 | 52,738 | Feb 23 04:40 PM |
Wall St. Cheat Sheet has been featured in these fine media outlets:
